Separate trust zones
Public marketing, organisation administration and protected clinical runtime are intentionally distinct.
Security is part of the architecture,
not a footer.
This prototype separates public, account, authenticated, clinical and internal surfaces. It does not expose patient data, production credentials, live hospital integrations or real clinical access.
Least privilege
Identity, roles, contextual access and evidence are designed as explicit system concerns.
Traceable decisions
Important access and operational events are intended to produce durable, reviewable evidence.
TRUST ARCHITECTURE v2Trust is a set of verifiable controls,
Trust is a set of verifiable controls,
not a collection of badges.
NeuraOps separates identity, access, evidence, resilience and data boundaries into explicit control domains. Certification and regulatory claims are intentionally omitted until independently established.
Who are you, and what may you do?
Organisation identity, actor verification, federation and contextual authorisation are distinct controls.
Architecture defined
Keep administrative and clinical data apart.
Public, account, organisation and protected clinical surfaces have separate trust boundaries and data expectations.
Boundary model defined
Important transitions should leave evidence.
Verification, agreement acceptance, entitlements and privileged actions are designed to produce traceable evidence.
Implementation staged
Availability, recovery and safe degradation.
Clinical operations should not depend on an AI service or a single external provider to remain understandable and operable.
Production controls pending
Responsible vulnerability reporting.
A public security disclosure path belongs in the production Trust Center with clear ownership and response expectations.
Planned for production
Dependencies should remain visible.
Subprocessors, hosting, identity and integration dependencies should be documented without implying certifications they do not confer.
Register to be established
SYSTEM STATUS LANGUAGE
One vocabulary across the company surface.
CompleteRequired evidence accepted.
ActiveCurrently effective and in force.
In ReviewBeing assessed; not yet final.
PendingRequired work has not finished.
BlockedCannot progress until a stated dependency is resolved.
Not StartedNo execution has begun.
REGULATORY & STANDARDS READINESSDesigned for cross-market trust,
Designed for cross-market trust,
without pretending certification.
NeuraOps uses current European, Saudi, UAE and international frameworks as design inputs for trust, privacy, cybersecurity, accessibility and interoperability. These are readiness targets, not claims of legal compliance or certification.
EHDS + GDPR + accessibility
Product architecture reflects stronger expectations around interoperability, access logging, secure identity, health-data protection and user control. Public digital experiences are designed toward WCAG 2.2-aligned accessibility.
Architecture alignedNext: formal legal and conformity mapping
PDPL + NCA cybersecurity controls
Privacy, data lifecycle, cloud and cybersecurity design should be mapped against Saudi PDPL obligations and applicable NCA controls such as ECC, DCC, CCC and critical-system controls where relevant.
Readiness mappingNext: applicability-by-deployment review
DHA / Abu Dhabi healthcare controls
Regional deployment packs should account for healthcare-specific requirements such as Dubai interoperability and health-data policies, NABIDH-related integration expectations, and Abu Dhabi ADHICS cybersecurity requirements.
Regional pack plannedNext: emirate-specific control mapping
ISO-led management systems
Security, privacy and continuity governance can be structured toward ISO/IEC 27001, ISO/IEC 27701 and ISO 22301 management-system principles, while avoiding any claim of certification until independently achieved.
Control baselineNext: evidence register + audit plan
TRUST RULE
NeuraOps will publish only evidence-backed statements: certified means certified, compliant means legally assessed, and “designed toward” remains explicitly different from both.
TRANSPARENCY & ASSURANCETrust grows when users can see
Trust grows when users can see
how the system is governed.
The production Trust Center should not only describe architecture. It should also expose the right transparency mechanisms: who to contact, how incidents are handled, what suppliers are used, and where limitations remain.
A clear path for responsible reporting.
Publish a monitored security contact, expected acknowledgement window and safe-harbour language when the operational process is ready.
PlannedMake accessibility feedback actionable.
Provide a route for users to report accessibility barriers, identify affected surfaces and track remediation without requiring a clinical support channel.
Architecture definedThird-party dependencies should be visible.
Maintain a current supplier/subprocessor register covering purpose, service category, relevant data role and material changes.
Register pendingSeparate detection, response and customer notice.
Define incident ownership, severity, evidence preservation, customer communication and jurisdiction-specific notification obligations before production use.
Operational policy pendingPlan for degraded operation, not only uptime.
Document recovery objectives, backup expectations, service dependencies and safe fallback behavior when external services—including AI—are unavailable.
Design principle activeMaterial changes should be traceable.
Version public policies and enterprise terms, record effective dates and communicate material updates through the appropriate organisation channel.
Version model definedEVIDENCE PRINCIPLEPublish proof proportional to the claim.
Architecture diagrams, policy versions, test evidence, audit outcomes and certification records should each support the specific statement being made. Marketing language should never outrun the underlying evidence.